지방세포 신호와 소화기 질환 = Review : Adipocyte Signals in Energy Balance and Digestive Diseases

다국어 초록 (Multilingual Abstract)

For the regulation of energy balance in various internal organs including gut, pancreas and liver, visceral adipose tissue and brain perform important sensing and signaling roles via neural and endocrine pathway. Among these, adipose tissue has been known as a simple energy-storing organ, which stores excess energy in triglyceride. However, it became apparent that adipocytes have various receptors related to energy homeostasis, and secrete adipocytokines by endocrine, paracrine and autocrine mechanisms. In this review, basic roles of adipocytes in energy homeostasis and the correlation between adipocyte signals and digestive diseases are discussed. (Korean J Gastroenterol 2006;48:67-74)

참고문헌 (Reference)

1 "cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant gene transcript 1)" 221 : 286-289, 1996

2 "Visfatin" 307 : 426-430, 2005

3 "Visceral fat" 228 : 1118-1123, 2003

4 "Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP" 51 : 2929-2935, 2002

5 "Tumor necrosis factor α:a key component of the obesity-diabetes link" 43 : 1271-1278, 1994

6 "Troglitazone, a ligand for peroxisome proliferator-activated receptor γ, inhibits chemically induced aberrant crypt foci in rats" 92 : 396-403, 2001

7 "Tissue factor gene expression in the adipose tissues of obese mice" 95 : 7591-7596, 1998

8 "The structures and functions of peroxisome proliferator-activated receptors (PPARs)" 63 : 557-564, 2005

9 "The role of peroxisome proliferator-activated receptor γ in colon cancer and inflammatory bowel disease" 127 : 1121-1123, 2003

10 "The role of leptin in NAFLD contender or pretender?" 38 : 841-843, 2004

11 "The pleiotropic functions of peroxisome proliferator-activated receptor gamma" 79 : 30-47, 2001

12 "The leptin receptor" 272 : 6093-6096, 1997

13 "The hormone resistin links obesity to diabetes" 409 : 307-312, 2001

14 "The gut and energy balance" 307 : 1909-1914, 2005

15 "The current biology of resistin" 255 : 439-447, 2004

16 "The continuing epidemics of obesity and diabetes in the United States" 286 : 1195-1200, 2001

17 "The adipocyte-secreted protein Acrp30 enhances hepatic insulin action" 7 : 947-953, 2001

18 "The adipocyte" 80 : 15-18, 1995

19 "Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice" 105 : 271-278, 2000

20 "Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo" 82 : 4196-4200, 1997

21 "Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver" 38 : 471-476, 2003

22 "Roles of degree of fat deposition and its localization on VEGF expression in adipocytes" 288 : 1128-1136, 2005

23 "Roles of PPARs in carcinogenesis" 63 : 584-588, 2005

24 "Relationship between serum leptin and fatty liver in Japanese male adolescent university students" 94 : 3328-3335, 1999

25 "Regulation of fibrinolysis in the development of atherothrombosis" 82 : 832-836, 1999

26 "Regulation of fasted blood glucose by resistin" 303 : 1195-1198, 2004

27 "Recent advances in PPARs research-basic and clinical aspects" 63 : 539-548, 2005

28 "Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer" 97 : 13275-13280, 2000

29 "Pre-heparin plasma lipoprotein lipase mass" 33 : 412-416, 2001

30 "Positional cloning of the mouse obese gene and its human homologue" 372 : 425-432, 1994

31 "Physiological role of adipose tissue" 60 : 329-339, 2001

32 "Peroxisome proliferator-activated receptor γ is induced during differentiation of colon epithelium cells" 162 : 331-340, 1999

33 "Peroxisome proliferator-activated receptor γ and metabolic disease" 70 : 341-367, 2001

34 "Peroxisome proliferator- activated receptors (PPARs) nuclear receptors at the crossroads between lipid metabolism and inflammation" 49 : 497-505, 2000

35 "PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs" 99 : 335-345, 1999

36 "PPARs-mediated intracellular signal transduction" 63 : 565-571, 2005

37 "PPAR alpha is necessary for the lipogenic action of hyperleptinemia on white adipose and liver tissue" 99 : 11848-11853, 2002

38 "Obesity, adiponectin and vascular inflammatory disease" 14 : 561-566, 2003

39 "Nuclear receptors I. PPARγ in the gastrointestinal tract" 282 : 581-585, 2002

40 "Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies" 61 : 5307-5310, 2001

41 "Molecular mechanisms of insulin resistance and obesity" 228 : 1111-1117, 2003

42 "Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta" 108 : 1105-1113, 1989

43 "Minireview" 144 : 3749-3756, 2003

44 "Minireview" 144 : 3765-3773, 2003

45 "Mechanisms of disease" 2 : 273-280, 2005

46 "Mechanisms of disease" 2 : 103-111, 2005

47 "Loss-of-function mutations in PPARγ associated with human colon cancer" 4 : 799-804, 1999

48 "Lipoatrophy revisited" 11 : 410-416, 2000

49 "Lipid overload and over-flow" 14 : 398-403, 2003

50 "Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells" 119 : 466-478, 2000

51 "Life without white fat" 12 : 3168-3181, 1998

52 "Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets" 97 : 8536-8541, 2000

53 "Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells" 279 : 4292-4304, 2004

54 "Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase" 415 : 339-343, 2002

55 "Leptin and the regulation of body weight in mammals" 395 : 763-770, 1998

56 "Leptin and the control of metabolism" 134 : 2455-2463, 2004

57 "Leptin and liver fibrosis" 122 : 1529-1532, 2002

58 "Interleukin-6 production in human subcutaneous abdominal adipose tissue" 543 : 373-378, 2002

59 "Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP1c in adipose tissue" 12 : 3182-3194, 1998

60 "Inflammatory alterations in mesenteric adipose tissue in Crohn’s disease" 117 : 73-81, 1999

61 "Inflammatory alterations in mesenteric adipose tissue in Crohn’s disease" 117 : 73-81, 1999

62 "Increased resistin gene and protein expression in human abdominal adipose tissue" 87 : 2407-, 2002

63 "Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance" 95 : 2409-2415, 1995

64 "IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance" 271 : 665-668, 1996

65 "Hypoadiponectinemia in obesity and type 2 diabetes" 86 : 1930-1935, 2001

66 "Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells" 98 : 2598-2603, 2001

67 "Functional abnormality of adipocytes in the metabolic syndrome" 62 : 1108-1112, 2004

68 "Fat cells" 45 : 119-146, 2005

69 "Enhanced expression of PAI-1 in visceral fat" 2 : 800-803, 1996

70 "Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin" 125 : 1796-1807, 2003

71 "Endogenous glucose production is inhibited by the adipose-derived protein Acrp30" 108 : 1875-1881, 2001

72 "Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics" 287 : 82-89, 2004

73 "Do regional differences in adipocyte biology provide new pathophysiological insights?" 24 : 276-283, 2003

74 "Differentiation and reversal of malignant changes in colon cancer through PPARγ" 4 : 1046-1052, 1998

75 "Decreased IRS-2 and increased SREBP- 1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice" 6 : 77-86, 2000

76 "Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys" 50 : 1126-1133, 2001

77 "Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis" 258 : 274-280, 2005

78 "Beyond insulin resistance in NASH" 40 : 46-54, 2004

79 "Banting lecture 2001" 51 : 7-18, 2002

80 "Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (PPARγ) heterodimer" 193 : 827-838, 2001

81 "Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation" 61 : 6213-6218, 2001

82 "Adipose tissue as an endocrine organ" 89 : 2548-2556, 2004

83 "Adipose tissue as an endocrine organ" 11 : 327-332, 2000

84 "Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro" 87 : 2084-2049, 2002

85 "Adipose cell apoptosis" 4 : 3-7, 2000

86 "Adiponectin, hepatocellular dysfunction and insulin sensitivity" 60 : 256-263, 2004

87 "Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase" 8 : 1288-1295, 2002

88 "Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice" 40 : 177-184, 2004

89 "Adiponectin knockout mice" 62 : 1067-1076, 2004

90 "Adipocytokines and metabolic syndrome - molecular mechanism and clinical implication" 62 : 1085-1090, 2004

91 "Activators of the nuclear receptor PPARγ enhance colon polyp formation" 4 : 1058-1061, 1998

92 "Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice" 4 : 1053-1057, 1998

93 "Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells" 276 : 31059-31066, 2001

94 "A role for preadipocytes as macrophage-like cells" 13 : 305-312, 1999

95 "A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response" 104 : 383-389, 1999